Comparative antimicrobial activity of gatifloxacin tested against Campylobacter jejuni including fluoroquinolone-resistant clinical isolates

Diagnostic Microbiology and Infectious Disease

Volumn 34, Issue 2, 1999, Pages 99-102

  Hayward, Carol L ^a   Erwin, Meredith E ^a   Barrett, Mary S ^a   Jones, Ronald N ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CIPROFLOXACIN; COTRIMOXAZOLE; ERYTHROMYCIN; GATIFLOXACIN; GENTAMICIN; LEVOFLOXACIN; METRONIDAZOLE; TETRACYCLINE;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; CAMPYLOBACTER JEJUNI; CONTROLLED STUDY; CROSS RESISTANCE; DILUTION; HUMAN; INTERMETHOD COMPARISON; MINIMUM INHIBITORY CONCENTRATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REGRESSION ANALYSIS;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; CAMPYLOBACTER INFECTIONS; CAMPYLOBACTER JEJUNI; FLUOROQUINOLONES; HUMANS; MICROBIAL SENSITIVITY TESTS;

EID: 0033016119     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(98)00074-1     Document Type: Article

References (15)

1. Allos B.M., Blaser M.J. Campylobacter jejuni and the expanding spectrum of related infections. Clin Infect Dis. 20:1995;1092-1101.
2. Baker C.N. The Etest and Campylobacter jejuni. Diagn Microbiol Infect Dis. 15:1992;469-472.
3. Consumers Union (1998) Chicken: How safe? How Tasty? Consumer Reports March 3, 1998.
4. Doctor's Guide to the Internet (1998) Antex Biologics receives patent for Campylobacter vaccine, February 24, 1998.
5. Fort Worth Star-Telegram (1998) February 21, 1998.
6. Gaudreau C., Gilbert H. Comparison of disc diffusion and agar dilution methods for antibiotic susceptibility testing of Campylobacter jejuni subsp. jejuni and Campylobacter coli. J Antimicrob Chemother. 39:1997;707-712.
7. Hosaka M., Kinoshita S., Toyama A., Otsuki M., Nishino T. Antibacterial properties of AM-1155, a new 8-methoxy quinolone. J Antimicrob Chemother. 36:1995;293-301.
8. Huang M., Baker Cn, Banerjee S., Tenover F.C. Accuracy of the Etest for determining antimicrobial susceptibilities of staphylococci, enterococci, Campylobacter jejuni, and gram-negative bacteria resistant to antimicrobial agents. J Clin Microbiol. 30:1992;3243-3248.
9. Kearney T.E., Larkin M.J., Levett P.N. The effect of slurry storage and anaerobic digestion on survival of pathogenic bacteria. J Appl Bacteriol. 74:1993;86-93.
10. Approved standard M7-A4 Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 4th ed . 1997;NCCLS, Wayne, PA.
11. Tentative standard M23-T3 Development of in vitro susceptibility testing and quality control parameters. Tentative guideline . 1998;NCCLS, Wayne, PA.
12. Perez-Trallero E, Otero F, Lopez-Lopateguic C, Montes M, Garcia-Arenzana JM, Gomariz M (1997) High prevelance of ciprofloxacin resistant Campylobacter jejuni/coli in Spain. (abstr C-21). In: Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. Toronto, Canada: American Society for Microbiology, p. 49.
13. Smith KE, Besser J, Bender J, Hogan J, Hedberg C, MacDonald K, Osterholm M (1997) Quinolone-resistant Campylobacter jejuni infections in Minnesota residents, 1996. (abstr C-20). In: Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. Toronto, Canada: American Society for Microbiology, p. 49.
14. Wakabayashi E., Mitsuhashi S. In vitro antibacterial activity of AM-1155, a novel 6-fluoro-8-methoxy quinolone. Antimicrob Agents Chemother. 38:1994;594-601.
15. Wise R., Brenwald N.P., Andrews J.M., Boswell F. The activity of the methylpiperazinyl fluoroquinolone CG 5501 A comparison with wither fluoroquinolones . J Antimicrob Chemother. 39:1997;447-452.